Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension
The state-of-the-art digital PETCT imaging system, highlights a significant advancement in the fight against cancer and detects other lesions offering patient centric services
The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
These plant locations include Ramagundam, Talcher Kaniha, Korba, Vindhyachal, Dadri, Barh, Solapur, North Karanpura, and Mauda
The companies will spread the adoption of the latest HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics
This study showed that patients taking 75mg of Olpasiran previously every 12 weeks presented a 40–50% reduction in LP(a)
This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition
Subscribe To Our Newsletter & Stay Updated
